<SEC-DOCUMENT>0001213900-20-027374-index.html : 20200918 <SEC-HEADER>0001213900-20-027374.hdr.sgml : 20200918 <ACCEPTANCE-DATETIME>20200918163618 ACCESSION NUMBER: 0001213900-20-027374 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200916 FILED AS OF DATE: 20200918 DATE AS OF CHANGE: 20200918 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LAPOINTE ANTHONY GREGG CENTRAL INDEX KEY: 0001331860 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14778 FILM NUMBER: 201184361 MAIL ADDRESS: STREET 1: PO BOX 83216 CITY: GAITHERSBURG STATE: MD ZIP: 20883-3216 FORMER NAME: FORMER CONFORMED NAME: Lapointe Gregg Anthony DATE OF NAME CHANGE: 20050630 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 </SEC-HEADER> <DOCUMENT> <TYPE>4 <SEQUENCE>1 <FILENAME>ownership.xml <DESCRIPTION>OWNERSHIP DOCUMENT <TEXT> Document 1 - file: ownership.html
Document 1 - RAW XML: ownership.xml
</DOCUMENT> </SEC-DOCUMENT>